Your session is about to expire
← Back to Search
Treatment Group for Epilepsy (HOBSCOTCH Trial)
N/A
Waitlist Available
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
HOBSCOTCH Trial Summary
This trial will test whether a phone intervention called HOBSCOTCH can improve health and quality of life for people with refractory epilepsy.
Eligible Conditions
- Epilepsy
HOBSCOTCH Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline & 8-10 weeks after baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline & 8-10 weeks after baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Quality of Life in Epilepsy - 31 score
Secondary outcome measures
Feasibility of HOBSCOTCH in the clinical setting
HOBSCOTCH Trial Design
1Treatment groups
Experimental Treatment
Group I: Treatment GroupExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Kessler FoundationLead Sponsor
173 Previous Clinical Trials
10,678 Total Patients Enrolled
NYU Langone HealthOTHER
1,367 Previous Clinical Trials
839,691 Total Patients Enrolled
25 Trials studying Epilepsy
3,013 Patients Enrolled for Epilepsy
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger